scholarly journals The Toxicological Effects of Heavy Fuel Oil Category Substances

2013 ◽  
Vol 33 (1_suppl) ◽  
pp. 95S-109S ◽  
Author(s):  
Richard H. McKee ◽  
Fred Reitman ◽  
Ceinwen Schreiner ◽  
Russell White ◽  
Jeffrey H. Charlap ◽  
...  

Heavy fuel oil (HFO) category substances are used to manufacture HFO, a product used in industrial boilers and marine diesel engines. Commercial HFOs and blending stream components are substances of complex and variable composition, composed of C20 to >C50 hydrocarbons, although lower molecular weight material may be added to reduce viscosity and improve flow characteristics. An HFO blending stream (catalytically cracked clarified oil [CCCO]) was tested for target organ and developmental toxicity in rats following repeated dermal administration at doses of 5, 25, or 50 mg/kg/d. In the repeated dose study, there was evidence of increased liver weights, reduced thymus weights, and reductions in hematological parameters with an overall no observed adverse effect level (NOAEL) of 5 mg/kg/d. In the developmental toxicity test, there were significant reductions in fetal survival, significant increases in resorption frequency, and significantly reduced fetal weights with an overall NOAEL of 5 mg/kg/d. These target organ and developmental effects are associated with the types and levels of aromatic constituents in these substances. Among HFO blending streams, CCCOs have the highest levels of aromatics and, because they produce the characteristic toxicological effects at the lowest levels, are considered as “reasonable worst-case examples” for this group of substances. Other HFO category members with lower levels of aromatics produce similar effects but have higher NOAELs. The potential for target organ and developmental effects of other HFO category members can be predicted from information on the types and levels of the aromatic constituents present in these substances.

2013 ◽  
Vol 33 (1_suppl) ◽  
pp. 78S-94S ◽  
Author(s):  
Richard H. McKee ◽  
Ceinwen A. Schreiner ◽  
Russell White ◽  
Mark Saperstein ◽  
Jeffrey H. Charlap ◽  
...  

Gas oils, used to manufacture diesel fuel and residential heating oil, are complex hydrocarbon substances with carbon numbers of C9-C30 and boiling ranges of approximately 150°C to 450°C. Target organ (liver enlargement, reduced thymus weights, and reductions in hematological parameters) and developmental (reduced fetal viability, increased resorption frequency, and reduced fetal weights) effects are associated with aromatic constituents present in some gas oils. Two types of gas oils were tested for repeated-dose and developmental toxicity following repeated dermal administration. A blend of commercial diesel fuels containing 26% aromatics, primarily single-ring compounds, did not cause either target organ or developmental effects at levels up to 600 mg/kg/d. “Cracked” gas oils containing higher levels of aromatic constituents were also tested. Because of limited sample availability, 2 cracked gas oil samples were tested, one for systemic effects and the other for developmental toxicity. The sample tested in the repeated-dose toxicity study (81% aromatics including approximately 10% 3-ring compounds) produced increased liver weights, reduced thymus weights, and reductions in hematological parameters. The overall no observed adverse effect level (NOAEL) was 100 mg/kg/d. The sample tested for developmental toxicity (65% aromatics including approximately 5% 3-ring compounds) resulted in significant reductions in fetal survival, significant increases in resorption frequency, and significant reductions in fetal weights with an overall NOAEL of 100 mg/kg/d. In summary, gas oils may or may not cause target organ and/or developmental effects depending on the levels and types of aromatic constituents that they contain.


2019 ◽  
Vol 38 (5) ◽  
pp. 395-404 ◽  
Author(s):  
David Crawford ◽  
Mitchell Friedman

Vedolizumab, a humanized monoclonal antibody approved for the treatment of adults with moderately to severely active ulcerative colitis or Crohn disease, targets α4β7 integrin and selectively blocks gut-specific lymphocyte trafficking. The potential effects of vedolizumab on development were assessed by standard preclinical toxicity studies in rabbits and cynomolgus monkeys. A single infusion of vedolizumab (0, 10, 30, or 100 mg/kg) was administered intravenously to pregnant rabbits on gestational day 7; rabbits were monitored to gestational day 29. Vedolizumab (0, 10, or 100 mg/kg) was administered intravenously every 2 weeks to pregnant cynomolgus monkeys beginning on gestational day 20 with the last dose on gestational day 132 (9 doses total). In rabbits, vedolizumab did not affect maternal net body weight or net gains, gravid uterine weights, or mean maternal food consumption, nor did it affect intrauterine growth or fetal survival. There were also no vedolizumab effects on embryo–fetal development compared to controls. In cynomolgus monkeys, there was no increase in prenatal loss/death or stillbirth and no maternal toxicity associated with vedolizumab. On day 28 postpartum, low levels of vedolizumab were detected in the breast milk of 3 of 11 monkeys in the 100 mg/kg group. No vedolizumab-related effects on the number of infants born, infant development, or animal hematology or clinical chemistry were noted. Administration of vedolizumab to pregnant rabbits and cynomolgus monkeys did not show any potential for maternal or developmental effects.


Author(s):  
Laís A. Nascimento ◽  
Marilda N. Carvalho ◽  
Mohand Benachour ◽  
Valdemir A. Santos ◽  
Leonie A. Sarubbo ◽  
...  

2017 ◽  
Vol 68 ◽  
pp. 203-215 ◽  
Author(s):  
Dionisis Stefanitsis ◽  
Ilias Malgarinos ◽  
George Strotos ◽  
Nikolaos Nikolopoulos ◽  
Emmanouil Kakaras ◽  
...  

1996 ◽  
Vol 26 (2) ◽  
pp. 2241-2250 ◽  
Author(s):  
M.A. Byrnes ◽  
E.A. Foumeny ◽  
T. Mahmud ◽  
A.S.A.K. Sharifah ◽  
T. Abbas ◽  
...  

Author(s):  
F. Mikaela Nordborg ◽  
Diane L. Brinkman ◽  
Gerard F. Ricardo ◽  
Susana Agustí ◽  
Andrew P. Negri

Author(s):  
Akili D. Khawaji ◽  
Jong-Mihn Wie

The most popular method of controlling sulfur dioxide (SO2) emissions in a steam turbine power plant is a flue gas desulfurization (FGD) process that uses lime/limestone scrubbing. Another relatively newer FGD technology is to use seawater as a scrubbing medium to absorb SO2 by utilizing the alkalinity present in seawater. This seawater scrubbing FGD process is viable and attractive when a sufficient quantity of seawater is available as a spent cooling water within reasonable proximity to the FGD scrubber. In this process the SO2 gas in the flue gas is absorbed by seawater in an absorber and subsequently oxidized to sulfate by additional seawater. The benefits of the seawater FGD process over the lime/limestone process and other processes are; 1) The process does not require reagents for scrubbing as only seawater and air are needed, thereby reducing the plant operating cost significantly, and 2) No solid waste and sludge are generated, eliminating waste disposal, resulting in substantial cost savings and increasing plant operating reliability. This paper reviews the thermodynamic aspects of the SO2 and seawater system, basic process principles and chemistry, major unit operations consisting of absorption, oxidation and neutralization, plant operation and performance, cost estimates for a typical seawater FGD plant, and pertinent environmental issues and impacts. In addition, the paper presents the major design features of a seawater FGD scrubber for the 130 MW oil fired steam turbine power plant that is under construction in Madinat Yanbu Al-Sinaiyah, Saudi Arabia. The scrubber with the power plant designed for burning heavy fuel oil containing 4% sulfur by weight, is designed to reduce the SO2 level in flue gas to 425 ng/J from 1,957 ng/J.


2021 ◽  
Vol 216 ◽  
pp. 106800
Author(s):  
Xinyan Pei ◽  
Paolo Guida ◽  
K.M. AlAhmadi ◽  
Ibrahim A. Al Ghamdi ◽  
Saumitra Saxena ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document